Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-17

Clinical Trial Update: Aspirin Versus Aspirin+Clopidogrel as Antithrombotic Treatment Following TAVI [Phase 4]

View source ↗

Summary

Phase 4 trial comparing aspirin alone to aspirin plus clopidogrel as antithrombotic therapy after transcatheter aortic valve implantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)
  • CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec | Conditions: Aortic Valve Disease, Myocardial Infarction | Phase 4 | Status: COMPLETED